Business Context and Reporting Period
This Form 8-K was filed by WiSA Technologies, Inc. (not Datavault AI Inc.) on February 13, 2025. The filing reports the entry into a Material Definitive Agreement regarding a registered direct offering of common stock and warrants.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $5.4 million.
- Offering Price: $1.14 per share (combined price for shares and warrants).
- Shares Issued: 4,757,126 shares of Common Stock.
- Warrants Issued: Warrants exercisable for up to 4,757,126 shares at an exercise price of $1.14 per share.
- Placement Agent Fees: 7.0% of gross proceeds plus up to $75,000 in expense reimbursement.
- Placement Agent Warrants: Warrants to purchase up to 475,713 shares (5.0% of the offering) at an exercise price of $1.425 per share.
Note: This filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement with certain investors and a Placement Agency Agreement with Maxim Group LLC. Key contractual obligations include:
- Lock-up Period: The Company is restricted from issuing or selling additional Common Stock or convertible securities for 30 days post-closing, unless required to satisfy Nasdaq listing requirements.
- Variable Rate Transaction Restriction: The Company cannot issue certain securities constituting a Variable Rate Transaction for 4 months post-closing, subject to Nasdaq listing exceptions.
- Warrant Terms: Investor warrants are immediately exercisable and expire on the fifth anniversary of issuance. Placement Agent warrants are exercisable 6 months after the commencement of sales and expire five years after the initial exercise date.
Outlook and Closing Status
The Offering is expected to close on February 14, 2025, subject to the satisfaction of customary closing conditions. The securities are being offered pursuant to the Company's effective shelf registration statement on Form S-3 (File No. 333-267211). The filing does not contain specific management commentary on future revenue guidance or operational risks beyond the standard terms of the financing.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected Feb 14, 2025) and confirmation of fund receipt.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific investor rights and covenants.
- Assess the dilution impact of the 4,757,126 new shares plus the potential issuance of 4,757,126 warrant shares and 475,713 placement agent warrant shares.
- Confirm the Company's current cash position and whether this $5.4 million infusion is sufficient to meet Nasdaq continued listing requirements.
- Check for any subsequent filings regarding the use of proceeds or changes to the offering terms.